We are committed to redefining healthcare: connecting the best of Health&Care for every provider, for every patient, for everyone. Imagine all the amazing things those two simple words can do.
Innovative Medicine
Johnson & Johnson Innovative Medicine is leading where medicine is going. Patients inform and inspire our science-based innovations, which continue to change and save lives. With rigorous science and compassion, we confidently address the most complex diseases of our time and unlock the potential medicines of tomorrow. Therapeutic areas include: Oncology, Immunology, Neuroscience, Cardiovascular, Pulmonary Hypertension, and Retina.
MedTech
Johnson & Johnson MedTech innovates at the intersection of biology and technology. With a focus on treating with pinpoint precision in the hardest-to-reach parts of the body, restoring anatomy and reimagining healing, our portfolio of smarter, less invasive, more personalized treatments is addressing the most complex diseases. Focus areas include: Interventional Solutions, Orthopaedics, Surgery and Vision.
Innovating in Health&Care
Getting in front of cancer
Every year, roughly 2 million people in the U.S. are newly diagnosed with cancer. But a number of scientific breakthroughs—including ones made at Johnson & Johnson—have dramatically changed what kind of prognosis many of these patients will have.
Inside the development of a revolutionary treatment for blood cancers
In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
Could we be on the cusp of catching Alzheimer’s before it starts?
The key to slowing cognitive decline is diagnosing the disease as early as possible. And that’s exactly what Johnson & Johnson scientists are relentlessly pursuing.
4 things to know about Johnson & Johnson’s 2023 Health for Humanity Report
The annual report details the company’s ongoing work in helping to create a healthier world, building a more diverse and inclusive workforce, championing global health equity and more.
“I’m a scientist dedicated to bringing eye-health innovations to the world”
Meet Xiao-Yu Song, Global Head of Research & Development for Vision at Johnson & Johnson, who leads a talented team that creates cutting-edge products addressing vision problems through all stages of life.
3 ways Johnson & Johnson is working to boost the number of diverse doctors
If people of color aren’t well represented in healthcare, then communities of color cannot receive truly equitable healthcare. These unique programs are supporting physicians from racial minority groups so they can better support the patients who need them.
5 things we now know about myasthenia gravis
For Myasthenia Gravis Awareness Month, discover more about the disease, learn how one woman lives with this rare autoantibody condition and why Johnson & Johnson is working to find new treatments for patients like her.
How robots are helping personalize knee replacement surgery
For Arthritis Awareness Month, learn the latest about this common procedure and how Johnson & Johnson MedTech is innovating to improve patient outcomes.
“I helped create the lens that treated my mom’s cataracts”
For Cataract Awareness Month, learn about one employee’s very personal mission to help restore vision for people who undergo cataract surgery.
Driving diversity in medical illustration
In honor of Juneteeth, learn how a new online database supported by Johnson & Johnson aims to promote racial health equity by increasing imagery of people of color.
“I couldn’t speak, walk or sit.” Inside a rare autoimmune disease that attacks the muscles
Elisa Glass was diagnosed with dermatomyositis, which causes severe muscle weakness throughout the body. For Myositis Awareness Month, she shares her story.
5 things we now know about bladder cancer
Paradigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. For Bladder Cancer Awareness Month, learn how Johnson & Johnson is helping to change the treatment landscape.
“Lung cancer wasn’t even on my radar. Then I was diagnosed.”
The disease is often detected late—which can have fatal consequences. But thanks to innovations in diagnostic tools, there’s a way to catch lung cancer earlier. Here’s how early detection saved one woman’s life.
What is IL-23?
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.